We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$7.58B
AUM Growth
+$139M
Cap. Flow
+$177M
Cap. Flow %
2.33%
Top 10 Hldgs %
25.49%
Holding
165
New
14
Increased
52
Reduced
27
Closed
13

Top Buys

Rank Stock Value
1
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$63.7M
2
FIVN icon
FIVE9
FIVN
+$52.6M
3
XMTR icon
Xometry
XMTR
+$50.4M
4
GLBE icon
Global E Online
GLBE
+$32.3M
5
FVRR icon
Fiverr
FVRR
+$31.6M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$83.1M
2
TRIL
Trillium Therapeutics Inc.
TRIL
+$50M
3
CLDX icon
Celldex Therapeutics
CLDX
+$46M
4
BBIO icon
BridgeBio Pharma
BBIO
+$43.4M
5
RNG icon
RingCentral
RNG
+$39.4M

Sector Composition

Rank Sector Weight
1 Healthcare 34.36%
2 Technology 30.11%
3 Industrials 12.97%
4 Consumer Discretionary 7.19%
5 Communication Services 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCN
26
Waste Connections
WCN
$41.9B
$101M 1.34%
804,000
– –
ARGX icon
27
argenx
ARGX
$54.6B
$101M 1.33%
333,000
– –
TRIL
28
DELISTED
Trillium Therapeutics Inc.
TRIL
$91.8M 1.21%
5,227,376
-4,282,624
-45% -$50M
KRTX
29
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$91.5M 1.21%
748,000
– –
TREX icon
30
Trex
TREX
$4.56B
$89.9M 1.19%
882,000
– –
ENTG icon
31
Entegris
ENTG
$17.8B
$89.4M 1.18%
709,999
+58,400
+9% +$7.04M
DHI icon
32
D.R. Horton
DHI
$40.7B
$88.6M 1.17%
1,055,493
– –
W icon
33
Wayfair
W
$11.9B
$85.5M 1.13%
334,477
+915
+0.3% +$258K
RXDX
34
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$85.1M 1.12%
3,714,032
– –
APTV icon
35
Aptiv
APTV
$12.3B
$80M 1.05%
537,000
– –
PANW icon
36
Palo Alto Networks
PANW
$265B
$72.8M 0.96%
911,922
+15,900
+2% +$1.12M
PRAX icon
37
Praxis Precision Medicines
PRAX
$8.58B
$70.5M 0.93%
254,040
+1,570
+0.6% +$426K
DDOG icon
38
Datadog
DDOG
$95.6B
$68.6M 0.9%
485,104
– –
ALLK
39
DELISTED
Allakos
ALLK
$66.7M 0.88%
630,000
+229,000
+57% +$20.5M
CLDX icon
40
Celldex Therapeutics
CLDX
$3.02B
$60.9M 0.8%
1,128,000
-980,908
-47% -$46M
DICE
41
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$59.2M 0.78%
+1,871,612
New +$63.7M
YETI icon
42
Yeti Holdings
YETI
$3.76B
$59.1M 0.78%
690,000
– –
MGA icon
43
Magna International
MGA
$19B
$58.7M 0.77%
780,000
-35,600
-4% -$2.93M
CCI icon
44
Crown Castle
CCI
$33.4B
$56.8M 0.75%
327,700
+14,600
+5% +$2.82M
SHLS icon
45
Shoals Technologies Group
SHLS
$1.49B
$53.1M 0.7%
1,905,060
+457,600
+32% +$14.2M
COLL icon
46
Collegium Pharmaceutical
COLL
$1.17B
$51.9M 0.68%
2,629,593
– –
VITL icon
47
Vital Farms
VITL
$536M
$51.8M 0.68%
2,950,000
-58,232
-2% -$1.05M
HASI icon
48
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$51.6M 0.68%
964,000
+263,800
+38% +$15M
A icon
49
Agilent Technologies
A
$39.2B
$50.8M 0.67%
322,300
+170,600
+112% +$27.6M
TSM icon
50
TSMC
TSM
$2.09T
$50.6M 0.67%
453,100
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Eventide Asset Management held 165 positions worth $7.58B, up 1.9% from $7.44B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management's Q3 2021 filing shows 14 new, 52 increased, 27 reduced and 13 closed positions. Its largest new stake was DICE Therapeutics, Inc. Common Stock: 1,871,612 shares worth $59.2M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $83.1M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q3 2021 buy was DICE Therapeutics, Inc. Common Stock: 1,871,612 shares worth $59.2M.
  • Eventide Asset Management added most to FIVE9 in Q3 2021, an estimated $52.6M increase.
  • Eventide Asset Management's biggest Q3 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $83.1M.
  • Eventide Asset Management fully exited BridgeBio Pharma in Q3 2021, selling an estimated $43.4M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $7.58B portfolio in Q3 2021.
  • Eventide Asset Management opened 14 new positions and closed 13 in Q3 2021.
  • Eventide Asset Management's portfolio value rose 1.9% quarter-over-quarter to $7.58B.

Based on Eventide Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.